Base10 Genetics
Robert Holton is a Board Member at BASE10 Genetics, where Robert managed a $25M OPEX budget and led a team of 140 across various departments. Robert was also the Chief Operating Officer and Chief Commercial Officer at VideoMedicine, overseeing strategy development and operations. Their experience includes roles at The Medicines Company, Equity Global Management, Blue Rock Capital, LLC, Q4 Industries, and Advanced Equities. Robert holds a Bachelor of Science in Finance with minors in Physics and Computer Science Engineering from The Johns Hopkins University.